The B-MYB transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Zhan, Ming ^a,b   Riordon, Daniel R ^a   Yan, Bin ^a,c   Tarasova, Yelena S ^a   Bruweleit, Sarah ^a   Tarasov, Kirill V ^a   Li, Ronald A ^d   Wersto, Robert P ^a   Boheler, Kenneth R ^a,d  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; POLO LIKE KINASE 1; PROTEIN B MYB; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FATE; CELL RENEWAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE CONTROL; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; MICE; MODELS, THEORETICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLURIPOTENT STEM CELLS; TRANS-ACTIVATORS;

EID: 84865292064     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042350     Document Type: Article

References (77)

1. Wobus AM, Boheler KR, (2005) Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85: 635-678.
2. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676 Epub 2006 Aug 2010.
3. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
4. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920 Epub 2007 Nov 1920.
5. Gore A, Li Z, Fung HL, Young JE, Agarwal S, et al. (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-U76.
6. Kim K, Doi A, Wen B, Ng K, Zhao R, et al. (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-U260.
7. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, et al. (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genetics 41: 1350-U1123.
8. Daley GQ, Lensch MW, Jaenisch R, Meissner A, Plath K, et al. (2009) Broader Implications of Defining Standards for the Pluripotency of iPSCs. Cell Stem Cell 4: 200-201.
9. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, et al. (2010) Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence. Stem Cells 28: 704-712.
10. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, et al. (2008) Marked differences in differentiation propensity among human embryonic stem cell lines. Nature Biotechnology 26: 313-315.
11. Han JY, Yuan P, Yang H, Zhang JQ, Soh BS, et al. (2010) Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 463: 1096-U1120.
12. Martin GR, (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634-7638.
13. Evans MJ, Kaufman MH, (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156.
14. Keller G, (2005) Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 19: 1129-1155.
15. Yu JY, Thomson JA, (2008) Pluripotent stem cell lines. Genes & Development 22: 1987-1997.
16. Orford KW, Scadden DT, (2008) Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nature Reviews Genetics 9: 115-128.
17. Hong YL, Stambrook PJ, (2004) Restoration of an absent G(1) arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proceedings of the National Academy of Sciences of the United States of America 101: 14443-14448.
18. Singh AM, Dalton S, (2009) The Cell Cycle and Myc Intersect with Mechanisms that Regulate Pluripotency and Reprogramming. Cell Stem Cell 5: 141-149.
19. Amabile G, Meissner A, (2009) Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends in Molecular Medicine 15: 59-68.
20. Stead E, White J, Faast R, Conn S, Goldstone S, et al. (2002) Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21: 8320-8333.
21. White J, Stead E, Faast R, Conn S, Cartwright P, et al. (2005) Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Molecular Biology of the Cell 16: 2018-2027.
22. Boheler KR, (2009) Stem Cell Pluripotency: A Cellular Trait That Depends on Transcription Factors, Chromatin State and a Checkpoint Deficient Cell Cycle. Journal of Cellular Physiology 221: 10-17.
23. Becker KA, Ghule PN, Therrien JA, Lian JB, Stein JL, et al. (2006) Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. Journal of Cellular Physiology 209: 883-893.
24. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, et al. (2005) LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896 Epub 2005 Jan 2026.
25. Smith K, Dalton S, (2010) Myc transcription factors: key regulators behind establishment and maintenance of pluripotency. Regenerative Medicine 5: 947-959.
26. Tanaka Y, Patestos NP, Maekawa T, Ishii S, (1999) B-myb is required for inner cell mass formation at an early stage of development. J Biol Chem 274: 28067-28070.
27. Tarasov KV, Tarasova YS, Tam WL, Riordon DR, Elliott ST, et al. (2008) B-MYB is Essential for Normal Cell Cycle Progression and Chromosomal Stability of Embryonic Stem Cells. PLoS One 3: e2478.
28. Lorvellec M, Dumon S, Maya-Mendoza A, Jackson D, Frampton J, et al. (2010) B-Myb is Critical for Proper DNA Duplication During an Unperturbed S Phase in Mouse Embryonic Stem Cells. Stem Cells 28: 1751-1759.
29. Schwab R, Caccamo A, Bettuzzi S, Anderson J, Sala A, (2007) B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: Implications for cell survival. Blood Cells Molecules and Diseases 39: 263-271.
30. Johnson TK, Schweppe RE, Septer J, Lewis RE, (1999) Phosphorylation of B-Myb regulates its transactivation potential and DNA binding. J Biol Chem 274: 36741-36749.
31. Bessa M, Saville MK, Watson RJ, (2001) Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator. Oncogene 20: 3376-3386.
32. Muller-Tidow C, Wang W, Idos GE, Diederichs S, Yang R, et al. (2001) Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function. Blood 97: 2091-2097.
33. Santilli G, Cervellera MN, Johnson TK, Lewis RE, Iacobelli S, et al. (2001) PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites. Oncogene 20: 8167-8174.
34. Petrovas C, Jeay S, Lewis RE, Sonenshein GE, (2003) B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain. Oncogene 22: 2011-2020.
35. Shepard JL, Amatruda JF, Stern HM, Subramanian A, Finkelstein D, et al. (2005) A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci U S A 102: 13194-13199 Epub 12005 Sep 13196.
36. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102: 15545-15550.
37. Meshorer E, Misteli T, (2006) Chromatin in pluripotent embryonic stem cells and differentiation. Nature Reviews Molecular Cell Biology 7: 540-546.
38. Zhao XD, Han X, Chew JL, Liu J, Chiu KP, et al. (2007) Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1: 286-298.
39. Pan GJ, Tian SL, Nie J, Yang CH, Ruotti V, et al. (2007) Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1: 299-312.
40. Mikkelsen TS, Ku MC, Jaffe DB, Issac B, Lieberman E, et al. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-U552.
41. McClelland SE, Borusu S, Amaro AC, Winter JR, Belwal M, et al. (2007) The CENP-A NAC/CAD kinetochore complex controls chromosome congression and spindle bipolarity. Embo Journal 26: 5033-5047.
42. Ruchaud S, Carmena M, Earnshaw WC, (2007) Chromosomal passengers: conducting cell division. Nature Reviews Molecular Cell Biology 8: 798-812.
43. Vader G, Lens SMA, (2008) The Aurora kinase family in cell division and cancer. Biochimica Et Biophysica Acta-Reviews on Cancer 1786: 60-72.
44. Chen X, Xu H, Yuan P, Fang F, Huss M, et al. (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133: 1106-1117.
45. Zhu W, Giangrande PH, Nevins JR, (2004) E2Fs link the control of G1/S and G2/M transcription. Embo J 23: 4615-4626 Epub 2004 Oct 4628.
46. Nakajima Y, Yamada S, Kamata N, Ikeda MA, (2007) Interaction of E2F-Rb family members with corepressors binding to the adjacent E2N site. Biochemical and Biophysical Research Communications 364: 1050-1055.
47. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, et al. (2008) Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134: 521-533.
48. Kim J, Chu J, Shen X, Wang J, Orkin SH, (2008) An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132: 1049-1061.
49. Yang JC, Chai L, Fowles TC, Alipio Z, Xu D, et al. (2008) Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 105: 19756-19761.
50. Wu Q, Chen X, Zhang J, Loh YH, Low TY, et al. (2006) Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J Biol Chem 281: 24090-24094 Epub 22006 Jul 24013.
51. Elling U, Klasen C, Eisenberger T, Anlag K, Treier M, (2006) Murine inner cell mass-derived lineages depend on SaII4 function. Proceedings of the National Academy of Sciences of the United States of America 103: 16319-16324.
52. Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, et al. (2006) Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 8: 1114-1123 Epub 2006 Sep 1117.
53. Yang JC, Gao C, Chai L, Ma YP, (2010) A Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells. Plos One 5.
54. Zhou Q, Chipperfield H, Melton DA, Wong WH, (2007) A gene regulatory network in mouse embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 104: 16438-16443.
55. Niwa H, Miyazaki J, Smith AG, (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372-376.
56. Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, et al. (2005) Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 123: 917-929.
57. Tarasov KV, Testa G, Tarasova YS, Kania G, Riordon DR, et al. (2008) Linkage of Pluripotent Stem Cell- Associated Transcripts to Regulatory Gene Networks. Cells Tissues Organs 27: 27.
58. Knight AS, Notaridou M, Watson RJ, (2009) A Lin-9 complex is recruited by B-Myb to activate transcription of G(2)/M genes in undifferentiated embryonal carcinoma cells. Oncogene 28: 1737-1747.
59. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313.
60. Bernstein BE, Mikkelsen TS, Xie XH, Kamal M, Huebert DJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
61. Isono K, Fujimura Y, Shinga J, Yamaki M, O-Wang J, et al. (2005) Mammalian polyhomeotic homologues Phc2 and Phc1 act in synergy to mediate polycomb repression of Hox genes. Molecular and Cellular Biology 25: 6694-6706.
62. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, et al. (2006) Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441: 349-353 Epub 2006 Apr 2019.
63. Li G, Margueron R, Ku MC, Chambon P, Bernstein BE, et al. (2010) Jarid2 and PRC2, partners in regulating gene expression. Genes & Development 24: 368-380.
64. Pasini D, Cloos PAC, Walfridsson J, Olsson L, Bukowski JP, et al. (2010) JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 464: 306-U193.
65. Sun Y, Li H, Liu Y, Mattson MP, Rao MS, et al. (2008) Evolutionarily Conserved Transcriptional Co-Expression Guiding Embryonic Stem Cell Differentiation. PloS One 3: e3406.
66. Cao R, Wang HB, He J, Erdjument-Bromage H, Tempst P, et al. (2008) Role of hPHF1 in H3K27 methylation and Hox gene silencing. Molecular and Cellular Biology 28: 1862-1872.
67. Cao R, Zhang Y, (2004) The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Current Opinion in Genetics & Development 14: 155-164.
68. Chamberlain SJ, Yee D, Magnuson T, (2008) Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells 26: 1496-1505.
69. Juan AH, Derfoul A, Feng XS, Ryall JG, Dell'Orso S, et al. (2011) Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells. Genes & Development 25: 789-794.
70. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T, (2003) Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424: 223-228.
71. Yamanaka S, Zahanich I, Wersto RP, Boheler KR, (2008) Enhanced proliferation of monolayer cultures of embryonic stem (ES) cell-derived cardiomyocytes following acute loss of retinoblastoma. PLoS ONE 3: e3896.
72. Mannefeld M, Klassen E, Gaubatz S, (2009) B-MYB Is Required for Recovery from the DNA Damage-induced G(2) Checkpoint in p53 Mutant Cells. Cancer Research 69: 4073-4080.
73. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC, (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 90: 8424-8428.
74. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, et al. (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70.
75. Tarasova YS, Riordon DR, Tarasov KV, Boheler KR (2006) In vitro differentiation of mouse ES cells to muscle cells. In: Notarianni E, Evans MJ, editors. Embryonic Stem Cells. New York: Oxford University Press. pp. 130-168.
76. Zahn JM, Poosala S, Owen AB, Ingram DK, Lustig A, et al. (2007) AGEMAP: a gene expression database for aging in mice. PLoS Genetics 3: e201.
77. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: 3.